A 3-year, Multicenter, Double-blind, Randomized, Placebo-controlled Extension to CZOL446H2301E1 to Evaluate the Efficacy and Long Term Safety of 6 and 9 Years Zoledronic Acid Treatment of Postmenopausal Women With Osteoporosis
收藏DataCite Commons2025-12-16 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012232/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This second extension will evaluate the efficacy and long term safety of zoledronic acid in women with post-menopausal osteoporosis
提供机构：
Vivli
创建时间：
2025-12-16
